NO20005990L - Platinumkompleks, dets fremstilling og terapeutiske anvendelse - Google Patents

Platinumkompleks, dets fremstilling og terapeutiske anvendelse

Info

Publication number
NO20005990L
NO20005990L NO20005990A NO20005990A NO20005990L NO 20005990 L NO20005990 L NO 20005990L NO 20005990 A NO20005990 A NO 20005990A NO 20005990 A NO20005990 A NO 20005990A NO 20005990 L NO20005990 L NO 20005990L
Authority
NO
Norway
Prior art keywords
preparation
therapeutic use
platinum complex
platinum
complex
Prior art date
Application number
NO20005990A
Other languages
English (en)
Other versions
NO328930B1 (no
NO20005990D0 (no
Inventor
Frantisek Zak
Milan Melka
Adolf Mistr
Jaroslav Turanek
Anna Poulova
Dana Zaluska
Original Assignee
Pliva Lachema As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Lachema As filed Critical Pliva Lachema As
Publication of NO20005990L publication Critical patent/NO20005990L/no
Publication of NO20005990D0 publication Critical patent/NO20005990D0/no
Publication of NO328930B1 publication Critical patent/NO328930B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
NO20005990A 1998-05-27 2000-11-27 Platinumkompleks, inklusjonskompleks derav, fremgangsmate for fremstilling derav samt terapeutisk sammensetning NO328930B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ19981628A CZ288912B6 (cs) 1998-05-27 1998-05-27 Komplex platiny v oxidačním čísle IV, způsob přípravy tohoto komplexu, tento komplex jako léčivo a farmaceutická kompozice tento komplex obsahující
PCT/CZ1999/000015 WO1999061451A1 (en) 1998-05-27 1999-05-24 Platinum complex, its preparation and therapeutic application

Publications (3)

Publication Number Publication Date
NO20005990L true NO20005990L (no) 2000-11-27
NO20005990D0 NO20005990D0 (no) 2000-11-27
NO328930B1 NO328930B1 (no) 2010-06-21

Family

ID=5463562

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005990A NO328930B1 (no) 1998-05-27 2000-11-27 Platinumkompleks, inklusjonskompleks derav, fremgangsmate for fremstilling derav samt terapeutisk sammensetning

Country Status (24)

Country Link
US (1) US6503943B1 (no)
EP (1) EP1082330B1 (no)
JP (1) JP3575686B2 (no)
CN (1) CN1124279C (no)
AU (1) AU741380B2 (no)
BG (1) BG64599B1 (no)
BR (1) BR9910669B1 (no)
CA (1) CA2332054C (no)
CZ (1) CZ288912B6 (no)
DE (1) DE69901177T2 (no)
ES (1) ES2175968T3 (no)
HR (1) HRP20000791B1 (no)
HU (1) HU224716B1 (no)
IL (1) IL139529A (no)
MX (1) MXPA00011621A (no)
NO (1) NO328930B1 (no)
PL (1) PL191132B1 (no)
PT (1) PT1082330E (no)
RS (1) RS49738B (no)
RU (1) RU2200164C2 (no)
SI (1) SI1082330T1 (no)
SK (1) SK284436B6 (no)
UA (1) UA56315C2 (no)
WO (1) WO1999061451A1 (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0408805A (pt) * 2003-03-31 2006-03-28 Pliva Lachema As composição farmacêutica contendo complexo de platina e método de fabricação da mesma
CZ296045B6 (cs) * 2003-03-31 2005-12-14 Pliva-Lachema A. S. Farmaceutická kompozice obsahující jako účinnou látku komplex čtyřmocné platiny a způsob její výroby
CZ2004235A3 (cs) * 2004-02-12 2005-08-17 Pliva-Lachema A. S. Farmaceutická kompozice obsahující jako účinnou látku platinový komplex a způsob výroby této kompozice
EP2298291A3 (en) 2004-06-18 2011-08-03 Agennix USA Inc. Kinase inhibitors for treating cancers
CA2573762A1 (en) * 2004-07-14 2006-02-23 Gpc Biotech Ag Variable-dose packaging system
CZ2004945A3 (cs) * 2004-09-08 2006-01-11 Pliva - Lachema A. S. Farmaceutická kompozice pro rektální nebo vaginální podání, zpusob její prípravy a tato kompozice pro pouzití jako lécivo
CZ2004964A3 (cs) * 2004-09-14 2006-03-15 Pliva-Lachema A. S. Perorální farmaceutická kompozice pro cílený transport komplexu platiny do kolorektální oblasti, zpusob její prípravy a tato kompozice pro pouzití jako lécivo
WO2007008247A2 (en) * 2004-11-10 2007-01-18 University Of South Florida Platinum complexes for targeted drug delivery
US20090047365A1 (en) * 2005-02-28 2009-02-19 Eisai R & D Management Co., Ltd. Novel Concomitant Use of Sulfonamide Compound with Anti-Cancer Agent
EP1792622A1 (en) 2005-11-11 2007-06-06 GPC Biotech AG Anti-proliferative combination therapy comprising a platinum-based chemotherapeutic agent and EGFR inhibitors or pyrimidine analogues
CZ300424B6 (cs) * 2006-06-20 2009-05-13 Pliva - Lachema A. S. Farmaceutická kompozice pro perorální podání
CZ300590B6 (cs) * 2006-06-20 2009-06-24 Pliva - Lachema A. S. Farmaceutická kompozice pro injekcní podání
CZ300120B6 (cs) * 2006-06-20 2009-02-11 Pliva - Lachema A. S. Farmaceutická kompozice pro injekcní podání
KR100829173B1 (ko) * 2006-09-19 2008-05-13 광주과학기술원 물에 대한 용해도가 우수한 플라틴 복합체의 포접복합체 및그 제조방법
GB2457453B (en) * 2008-02-12 2010-05-12 Pliva Lachema As Polymorphic crystalline form III of (OC-6-43)-bis(acetate)(1-tricyclo[3,3,1,13,7]decylamine) ammine dichloroplatinum (IV)
GB2457454B (en) * 2008-02-12 2010-05-12 Pliva Lachema As Polymorphic crystalline form II of (OC-6-43)-bis(acetate)(1-tricyclo[3,3,1,13,7]decylamine) ammine dichloroplatinum (IV)
GB2457455B (en) * 2008-02-12 2010-04-21 Pliva Lachema As Polymorphic crystalline form (I) of (OC-6-43)-Bis(Acetato)-1-(Tricyclo[3,3,1,1 (3,7)]Decylamine)Amminedichloroplatinum(IV)
GB2457452B (en) * 2008-02-12 2010-05-12 Pliva Lachema As Amorphous form of (OC-6-43)-bis(acetate)(1-tricyclo[3,3,1,13,7]decylamine) amminedichloroplatinum (IV)
WO2010149666A1 (en) 2009-06-22 2010-12-29 Medexis S.A. Methods for treating neoplasia
US20120238488A1 (en) 2009-09-08 2012-09-20 Konstantinos Alevizopoulos Compounds and methods for treating neoplasia
EP2598513A1 (en) 2010-07-30 2013-06-05 Medexis S.A. Compounds and methods for treating neoplasia
AU2014405305B2 (en) * 2014-09-03 2019-09-19 Vuab Pharma A.S. Platinum (IV) complex with increased antitumor efficacy
CN104984356A (zh) * 2015-05-14 2015-10-21 昆明贵研药业有限公司 赛特铂的环糊精复合物及制备方法
RU2613513C2 (ru) * 2015-07-17 2017-03-16 Федеральное государственное бюджетное учреждение науки Институт проблем химической физики Российской академии наук (ИПХФ РАН) Способ получения комплексов платины (IV) с аминонитроксильными радикалами
RU2726826C2 (ru) * 2016-12-27 2020-07-15 Общество с ограниченной ответственностью "Плат-АН" (ООО "Плат-АН") Композиция на основе аминонитроксильного комплекса платины и доксорубицина и способ лечения опухолей
FI4025581T3 (fi) 2019-09-05 2024-03-01 Vuab Pharma A S Uusia platina(iv)-komplekseja, joilla on olennaisesti suurempi kasvaimen vastainen teho

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68918878T2 (de) * 1988-02-02 1995-02-23 Johnson Matthey Inc Pt(IV) Komplexe.
FI905018A7 (fi) * 1989-10-17 1991-04-18 Bristol Myers Squibb Co Veteen ja liuottimeen liukenevat aksiaaliset hydroksi- ja mono- ja di-karboksyylihappojohdannaiset, joilla on korkea kasvainaktiivisuus
GB9105037D0 (en) * 1991-03-09 1991-04-24 Johnson Matthey Plc Improvements in chemical compounds
RU2089555C1 (ru) * 1995-05-04 1997-09-10 Новосибирский институт биоорганической химии СО РАН Бисимидазол-(1,10)-фенантролинплатина (iii) дихлорид, проявляющий цитостатическую противоопухолевую активность
JPH10265380A (ja) * 1997-03-17 1998-10-06 Bristol Myers Squibb Co 抗ガン剤

Also Published As

Publication number Publication date
IL139529A (en) 2004-06-20
WO1999061451A1 (en) 1999-12-02
CN1124279C (zh) 2003-10-15
RS49738B (sr) 2008-04-04
CA2332054A1 (en) 1999-12-02
AU3809399A (en) 1999-12-13
PL344346A1 (en) 2001-11-05
SI1082330T1 (en) 2002-08-31
ES2175968T3 (es) 2002-11-16
EP1082330B1 (en) 2002-04-03
MXPA00011621A (es) 2003-03-12
AU741380B2 (en) 2001-11-29
PL191132B1 (pl) 2006-03-31
BG64599B1 (bg) 2005-08-31
CZ288912B6 (cs) 2001-09-12
BR9910669A (pt) 2001-01-30
SK284436B6 (sk) 2005-04-01
HRP20000791A2 (en) 2001-02-28
YU71900A (sh) 2002-10-18
DE69901177T2 (de) 2002-10-02
BG104972A (en) 2001-08-31
BR9910669B1 (pt) 2011-07-26
HU224716B1 (en) 2006-01-30
NO328930B1 (no) 2010-06-21
HUP0102549A2 (hu) 2001-11-28
CN1303388A (zh) 2001-07-11
HUP0102549A3 (en) 2004-04-28
CA2332054C (en) 2005-06-28
CZ162898A3 (cs) 1999-12-15
RU2200164C2 (ru) 2003-03-10
EP1082330A1 (en) 2001-03-14
JP2002516332A (ja) 2002-06-04
DE69901177D1 (de) 2002-05-08
PT1082330E (pt) 2002-09-30
JP3575686B2 (ja) 2004-10-13
HRP20000791B1 (en) 2006-07-31
NO20005990D0 (no) 2000-11-27
SK17732000A3 (sk) 2001-05-10
US6503943B1 (en) 2003-01-07
IL139529A0 (en) 2001-11-25
UA56315C2 (uk) 2003-05-15

Similar Documents

Publication Publication Date Title
NO20005990L (no) Platinumkompleks, dets fremstilling og terapeutiske anvendelse
NO20012567D0 (no) Azepinoindolderivater, fremstilling og anvendelse derav
NO20021449D0 (no) Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og anvendelse derav
NO20012158D0 (no) Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav
NO993619D0 (no) Titandioksid, fremstilling og anvendelse derav
IS5696A (is) Mótefni gegn CD23, afleiður þeirra og meðferðarnotkun þeirra
NO20014560D0 (no) Quinasoliner og terapautisk anvendelse derav
DK0870003T3 (da) Hydrobehandlingskatalysator: sammensætning, fremstilling og anvendelse deraf
DK1233964T3 (da) Ny anvendelse og hidtil ukendte N-azabicycloamidderivater
NO20021379D0 (no) Benzodiazepin-derivater, fremstilling og anvendelse derav
DK1019358T3 (da) 3,3-diarylpropylaminer, deres anvendelse og fremstilling
DK1073672T3 (da) Antipicornavirale forbindelser, deres fremstilling og anvendelse
NO20005146L (no) Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter
NO951447D0 (no) Organoaluminoksyprodukt, fremstilling og anvendelse
IS6420A (is) Setnar Fenýl-píperazín afleiður, framleiðsla þeirra og notkun
DK1417189T3 (da) Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
DK1202996T3 (da) Titanforbindelser, fremstilling og anvendelse heraf
NO20005919D0 (no) Platinakompleks, dets fremstilling og terapeutisk anvendelse
DK1025100T3 (da) 3-substituerede tetrahydropyridopyrimidinonderivater, fremstilling og anvendelsen heraf
NO20012738D0 (no) Terapeutiske produkter og anvendelse derav
NO20020919L (no) Irenprotein, dets fremstilling og anvendelse
EE200000018A (et) 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine
NO20006479D0 (no) Tienopyridinforbindelser, deres fremstilling og anvendelse
NO996156L (no) Substituerte cykloheptener, deres fremstilling og anvendelse
NO20014300L (no) Nytt protein og dets anvendelse

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees